Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Glaucoma
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Glaucoma
    TopAbstracts in Glaucoma 08/25/2008 - (DGNews)
    TopAbstracts in Glaucoma 07/28/2008 - (DGNews)
    Sandoz Timolol Ophthalmic Solution Recalled Due to Potential Health Risk - (DGNews)
    TopAbstracts in Glaucoma 06/30/2008 - (DGNews)
    FDA Approves Triamcinolone Acetone Formulation for Ocular Use - (DGNews)

    News archive

     Recent webcasts/CME - Glaucoma
      Enhancing Adherence with Glaucoma Therapy: Practical Strategies for Superior Outcomes
      Glaucoma Progression: Detection and Management
      Managing Concomitant Eye Diseases: Expert Views on Glaucoma and Dry Eye
      Topics in Glaucoma Management: Systemic Effects of Medications
      Update on Glaucoma Treatment: ACT: Applying Trial Data on Fixed-Combination Therapy to Daily Clinical Practice

      Webcasts/CME archive

       Recent cases - Glaucoma
        Good Functional Recovery Following Intervention for Delayed Suprachoroidal Haemorrhage Post Bleb Needling: A Case Report
        Acute Bilateral Simultaneous Angle Closure Glaucoma After Topiramate Administration
        Topiramate-Induced Bilateral Angle-Closure Glaucoma
        Bilateral Acute Angle Closure Glaucoma as a Presentation of Isolated Microspherophakia in an Adult: Case Report
        Vascular Compression of the Optic Chiasm Resembling Glaucoma-Like Visual Field Defects

        Cases archive
          




        my personal edition > glaucoma > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Epithelial Barrier Function Remains Intact Following Topical Latanoprost for Glaucoma

        A DGReview of :"Influence of Latanoprost on the Corneal Epithelial Barrier Function in Glaucoma Patients."
        Ophthalmologica

        11/18/2002
        By Mark Moran


        The corneal epithelial barrier function appears to remain intact following administration of topical latanoprost for glaucoma.

        Researchers at the Kyoto Prerfectural University of Medicine, Kyoto, Japan, evaluated the influence of topically administered latanoprost on corneal epithelial barrier function in 10 patients with no prior topical antiglaucoma medication and 14 patients already receiving medication.

        The 10 treatment-naïve patients received topical latanoprost (0.005%) once daily for 30 days, while the 14 patients receiving combination therapy were given the same dose once daily for 180 days. Corneal epithelial barrier function was measured before and after treatment in each group with a fluorophotometric technique.

        The mean fluorescein uptakes in the monotherapy group were 54.6 ng/ml and 57.1 ng/ml before and 30 days after treatment, respectively (p = 0.81). In the combination group, the mean uptakes were 101.0 ng/ml before treatment, 118.9 ng/ml after 30 days of treatment (p = 0.38) and 93.4 ng/ml (p = 0.58) after 180 of treatment.
        Ophthalmologica 2002 Sep-Oct;216(5):351-4. "Influence of Latanoprost on the Corneal Epithelial Barrier Function in Glaucoma Patients."

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send